EVpedia: a community web portal for extracellular vesicles research

  • Dae-Kyum Kim
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Jaewook Lee
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Sae Rom Kim
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Dong-Sic Choi
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Yae Jin Yoon
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Ji Hyun Kim
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Gyeongyun Go
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Dinh Nhung
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Kahye Hong
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Su Chul Jang
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Si-Hyun Kim
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Kyong-Su Park
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Oh Youn Kim
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Hyun Taek Park
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Ji Hye Seo
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Elena Aikawa
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Monika Baj-Krzyworzeka
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Bas W. M. van Balkom
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Mattias Belting
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Lionel Blanc
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Vincent Bond
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Antonella Bongiovanni
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Francesc E. Borràs
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Luc Buée
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Edit I. Buzás
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Lesley Cheng
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Aled Clayton
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Emanuele Cocucci
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Charles S. Dela Cruz
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Dominic M. Desiderio
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Dolores Di Vizio
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Karin Ekström
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Juan M. Falcon-Perez
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Chris Gardiner
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Bernd Giebel
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • David W. Greening
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Julia Christina Gross
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Dwijendra Gupta
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • An Hendrix
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Andrew F. Hill
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Michelle M. Hill
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Esther Nolte-'t Hoen
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Do Won Hwang
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Jameel Inal
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Medicharla V. Jagannadham
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Muthuvel Jayachandran
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Young-Koo Jee
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Malene Jørgensen
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Kwang Pyo Kim
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Yoon-Keun Kim
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Thomas Kislinger
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Cecilia Lässer
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Dong Soo Lee
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Hakmo Lee
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Johannes van Leeuwen
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Thomas Lener
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Ming-Lin Liu
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Jan Lötvall
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Antonio Marcilla
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Suresh Mathivanan
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Andreas Möller
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Jess Morhayim
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • François Mullier
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Irina Nazarenko
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Rienk Nieuwland
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Diana N. Nunes
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Ken Pang
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Jaesung Park
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Tushar Patel
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Gabriella Pocsfalvi
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Hernando del Portillo
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Ulrich Putz
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Marcel I. Ramirez
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Marcio L. Rodrigues
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Tae-Young Roh
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Felix Royo
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Susmita Sahoo
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Raymond Schiffelers
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Shivani Sharma
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Pia Siljander
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Richard J. Simpson
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Carolina Soekmadji
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Philip Stahl
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Allan Stensballe
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Ewa Stępień
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Hidetoshi Tahara
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Arne Trummer
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Hadi Valadi
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Laura J. Vella
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Sun Nyunt Wai
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Kenneth Witwer
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • María Yáñez-Mó
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Hyewon Youn
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Reinhard Zeidler
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re
  • Yong Song Gho
    1 Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea, 2Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, Republic of Korea, 3Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, 4Department of Clinical Immunology, Polish-American Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland, 5Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands, 6Section of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden, 7The Feinstein Institute for Medical Research, Manhasset, NY, USA, 8Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, 9Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, 10Innovation in Vesicles and Cells for Application in Therapy, Germans Trias i Pujol Re

Abstract

<jats:title>Abstract</jats:title> <jats:p>Motivation: Extracellular vesicles (EVs) are spherical bilayered proteolipids, harboring various bioactive molecules. Due to the complexity of the vesicular nomenclatures and components, online searches for EV-related publications and vesicular components are currently challenging.</jats:p> <jats:p>Results: We present an improved version of EVpedia, a public database for EVs research. This community web portal contains a database of publications and vesicular components, identification of orthologous vesicular components, bioinformatic tools and a personalized function. EVpedia includes 6879 publications, 172 080 vesicular components from 263 high-throughput datasets, and has been accessed more than 65 000 times from more than 750 cities. In addition, about 350 members from 73 international research groups have participated in developing EVpedia. This free web-based database might serve as a useful resource to stimulate the emerging field of EV research.</jats:p> <jats:p>Availability and implementation: The web site was implemented in PHP, Java, MySQL and Apache, and is freely available at http://evpedia.info.</jats:p> <jats:p>Contact:  ysgho@postech.ac.kr</jats:p>

Journal

  • Bioinformatics

    Bioinformatics 31 (6), 933-939, 2014-11-10

    Oxford University Press (OUP)

Citations (6)*help

See more

References(49)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top